JSA Advocates & Solicitors (JSA) advised Zota Health Care Limited on its Qualified Institutions Placement (“QIP“) aggregating to approximately INR 350 crores. Zota is the leading player in the generic pharmacy space, with its brand of Davaindia stores across India. ICICl Securities Limited acted as the BRLM to the QIP.
The Capital Markets practice of JSA advised on the transaction. The transaction involved sale of 22,80,130 equity shares of face value of INR 10 each, for an aggregate value of approximately INR 350 crores.
The JSA Capital Markets Team was led by Partner Arka Mookerjee, with support from Pracheta Bhattacharya, Partner; Kairav Parikh, Principal Associate; Vatsla Varandani, Senior Associate; Sourav Jena, Associate and Ishika Jain, Associate.
Arka Mookerjee is a Partner and Co-Head of the Equity Capital Markets practice, with over 21 years of experience advising on India’s most complex and high-value transactions. Widely recognised for pioneering mandates—including India’s first QIP and InvIT IPO—he represents issuers, underwriters and investors across capital markets and investment structures. Arka actively engages with regulators and industry bodies, playing a key role in shaping India’s evolving capital markets framework.